Beginning on June 27, physicians obtaining a new Drug Enforcement Administration (DEA) registration or renewing their current registration are required to attest to training requirements under the federal Medication Access and Training Expansion Act, passed as part of the Consolidated Appropriations Act, 2023 (P.L. 117-328). The law requires physicians to complete eight hours of training “on the treatment and management of patients with opioid or other substance use disorders.”
A guidance document issued by the DEA is available here. Resources from the American Medical Association — including educational opportunities to satisfy the DEA training — are available here.
